D-chiro-inositol phosphoglycan expression in human placenta at term in diabetes

Archives of Gynecology and Obstetrics

Volumn 288, Issue 2, 2013, Pages 459-460

  Scioscia, Marco ^a   Pesci, Anna ^b   Zamboni, Giuseppe ^b   Huppertz, Berthold ^c   Resta, Leonardo ^d  

^a Sacro Cuore Don Calabria Hospital   (Italy)

^b Sacro Cuore Don Calabria ^*  (Italy)

^c MEDICAL UNIVERSITY OF GRAZ   (Austria)

^d POLICLINICO   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRO CHIRO INOSITOL PHOSPHOGLYCAN; GLYCAN DERIVATIVE; MITOGEN ACTIVATED PROTEIN KINASE; SOMATOMEDIN C RECEPTOR; UNCLASSIFIED DRUG;

CLINICAL ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; FEMALE; HUMAN; INSULIN SENSITIVITY; LETTER; PLACENTA; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN LOCALIZATION; SIGNAL TRANSDUCTION; SYNCYTIOTROPHOBLAST;

DIABETES MELLITUS; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; INOSITOL PHOSPHATES; PLACENTA; POLYSACCHARIDES; PREGNANCY;

EID: 84880849135     PISSN: 09320067     EISSN: 14320711     Source Type: Journal    
DOI: 10.1007/s00404-013-2729-8     Document Type: Letter

References (9)

1. Huppertz B (2011) Placental pathology in pregnancy complications. Thromb Res 127(Suppl 3):S96-S99
2. Laviola L, Perrini S, Belsanti G, Natalicchio A, Montrone C, Leonardini A, Vimercati A, Scioscia M, Selvaggi L, Giorgino R, Greco P, Giorgino F (2005) Intrauterine growth restriction in humans is associated with abnormalities in placental insulin-like growth factor signaling. Endocrinology 146:1498-1505
3. Kunjara S, Greenbaum AL, Wang DY, Caro HN, McLean P, Redman CW, Rademacher TW (2000) Inositol phosphoglycans and signal transduction systems in pregnancy in preeclampsia and diabetes: evidence for a significant regulatory role in preeclampsia at placental and systemic levels. Mol Genet Metab 69:144-158
4. Larner J (2002) d-chiro-inositol - its functional role in insulin action and its deficit in insulin resistance. Int J Exp Diabetes Res 3:47-60
5. Scioscia M, Gumaa K, Kunjara S, Paine MA, Selvaggi LE, Rodeck CH, Rademacher TW (2006) Insulin resistance in human preeclamptic placenta is mediated by serine phosphorylation of insulin receptor substrate-1 and -2. J Clin Endocrinol Metab 91:709-717
6. Corrado F, D'Anna R, Di Vieste G, Giordano D, Pintaudi B, Santamaria A, Di Benedetto A (2011) The effect of myoinositol supplementation on insulin resistance in patients with gestational diabetes. Diabet Med 28(8):972-975
7. Scioscia M, Kunjara S, Gumaa K, McLean P, Rodeck CH, Rademacher TW (2007) Urinary excretion of inositol phosphoglycan P-type in gestational diabetes mellitus. Diabet Med 24(11):1300-1304
8. Scioscia M, Kunjara S, Gumaa K, Gomez Galan AM, McLean P, Rodeck CH, Rademacher TW (2007) Altered urinary release of inositol phosphoglycan A-type in women with gestational diabetes mellitus. Gynecol Obstet Invest 64(4):217-223
9. Kunjara S, Wang DY, Greenbaum AL, McLean P, Kurtz A, Rademacher TW (1999) Inositol phosphoglycans in diabetes and obesity: urinary levels of IPG A-type and IPG P-type, and relationship to pathophysiological changes. Mol Genet Metab 68(4):488-502